These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15084701)

  • 1. Gene-expression profiling in acute myeloid leukemia.
    Grimwade D; Haferlach T
    N Engl J Med; 2004 Apr; 350(16):1676-8. PubMed ID: 15084701
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene expression profiling in acute myeloid leukemia.
    Bullinger L
    Haematologica; 2006 Jun; 91(6):733-8. PubMed ID: 16769574
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute leukemia: subtype discovery and prediction of outcome by gene expression profiling.
    Downing JR
    Verh Dtsch Ges Pathol; 2003; 87():66-71. PubMed ID: 16888896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances.
    Mrózek K; Döhner H; Bloomfield CD
    Curr Opin Hematol; 2007 Mar; 14(2):106-14. PubMed ID: 17255787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene profiling of lymphoma, myeloma, and AML.
    Rogge L; Bianchi E
    MedGenMed; 2003 Jul; 5(3):12. PubMed ID: 14600649
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
    Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
    Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gene expression analysis of AML cells using cDNA microarray].
    Okutsu J; Nakamura Y
    Rinsho Ketsueki; 2002 May; 43(5):319-22. PubMed ID: 12096477
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives.
    Falini B; Sportoletti P; Martelli MP
    Curr Opin Oncol; 2009 Nov; 21(6):573-81. PubMed ID: 19770764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The diagnosis of acute myeloid leukaemia enhanced by using DNA microarrays].
    Löwenberg B; Delwel HR; Valk PJ
    Ned Tijdschr Geneeskd; 2005 Mar; 149(12):623-5. PubMed ID: 15813428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of acute myeloid leukemia and its impact on treatment.
    Frankfurt O; Licht JD; Tallman MS
    Curr Opin Oncol; 2007 Nov; 19(6):635-49. PubMed ID: 17906465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mining gene expression data.
    Patterson M
    Nat Rev Genet; 2000 Dec; 1(3):165. PubMed ID: 11252739
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurofibromatosis 1, and Not TP53, seems to be the main target of chromosome 17 deletions in de novo acute myeloid leukemia.
    Suela J; Largo C; Ferreira B; Alvarez S; Robledo M; González-Neira A; Calasanz MJ; Cigudosa JC
    J Clin Oncol; 2007 Mar; 25(9):1151-2; author reply 1152-3. PubMed ID: 17369586
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of a human acute myeloid leukaemia screening panel and consequent identification of novel gene mutation in FLT3 and CCND3.
    Smith ML; Arch R; Smith LL; Bainton N; Neat M; Taylor C; Bonnet D; Cavenagh JD; Andrew Lister T; Fitzgibbon J
    Br J Haematol; 2005 Feb; 128(3):318-23. PubMed ID: 15667533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of murine retroviral mutagenesis for identification of disease genes in human acute myeloid leukemia.
    Erkeland SJ; Verhaak RG; Valk PJ; Delwel R; Löwenberg B; Touw IP
    Cancer Res; 2006 Jan; 66(2):622-6. PubMed ID: 16423987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: prognostic implications.
    Baldus CD; Thiede C; Soucek S; Bloomfield CD; Thiel E; Ehninger G
    J Clin Oncol; 2006 Feb; 24(5):790-7. PubMed ID: 16418499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis.
    Larramendy ML; Niini T; Elonen E; Nagy B; Ollila J; Vihinen M; Knuutila S
    Haematologica; 2002 Jun; 87(6):569-77. PubMed ID: 12031912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder.
    Hasle H; Lund B; Nyvold CG; Hokland P; Østergaard M
    Leuk Res; 2006 May; 30(5):543-6. PubMed ID: 16242775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia.
    Trnková Z; Bedrlíková R; Marková J; Michalová K; Stöckbauer P; Schwarz J
    Neoplasma; 2007; 54(5):383-90. PubMed ID: 17688368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the p53 gene in acute myeloid leukemia patients correlate with poor prognosis.
    Melo MB; Ahmad NN; Lima CS; Pagnano KB; Bordin S; Lorand-Metze I; SaAd ST; Costa FF
    Hematology; 2002 Feb; 7(1):13-9. PubMed ID: 12171773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A gene selection algorithm based on the gene regulation probability using maximal likelihood estimation.
    Wang HQ; Huang DS
    Biotechnol Lett; 2005 Apr; 27(8):597-603. PubMed ID: 15973495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.